Merck’s Welireg receives conditional EU approval for VHL disease-associated tumors and advanced RCC, expanding its global presence across 30+ countries.
Europe Approves Merck’s Cancer Drug For Two Indications
Where Today's News Shapes Tomorrow
February 18, 2026
Headlines
